[1]
Mina Golestani et al. 2016. Cost Components of Treatment Protocols of Haemophilia Patients with Inhibitors Using Bypassing Agents in Iran: Cost Components of Treatment Protocols of Haemophilia Patients. Iranian Journal of Pharmaceutical Sciences. 12, 2 (Apr. 2016), 85–90. DOI:https://doi.org/10.22037/ijps.v12.40780.